Optimal sequencing strategies in metastatic colorectal cancer
Dr. Heinz-Josef Lenz, MD, discusses optimal sequencing strategies for the treatment of patients with metastatic colorectal cancer (mCRC): Numerous therapeutic agents are currently available for the treatment of mCRC. This makes the sequencing, or the order in which these agents are administered, an important factor in opt...
CONTINUE READING
ESMO Virtual Congress 2020: Colorectal cancer highlights
The European Society for Medical Oncology ESMO Virtual Congress 2020 took place last month, uniting clinicians and researchers from around the world to present new developments in oncology aimed at improving cancer patient care. Improvements seen in health-related QoL with first-line pembrolizumab for DNA repair-deficient...
CONTINUE READING
Welcoming Our Newest CCC Ambassador, Jesse Fishman!
Jesse Fishman is a 17-year-old hockey player, currently playing for the Kitchener Rangers in the Ontario Hockey League. Jesse’s life was changed forever last February when his mother was diagnosed with stage 3b colon cancer at the age of 45. Jesse has joined forces with Colorectal Cancer Canada with the goal of reducing the misc...
CONTINUE READING
Do young diabetes patients need early CRC screening?
12 August 2020 Recent findings from a Swedish cohort study found that people with diabetes had an increased risk of colorectal cancer (CRC), a risk similar to individuals with a family history of CRC. The study included over 12 million individuals of varying age groups. Analysis of the data found: • Among individuals who wer...
CONTINUE READING
Cancer Recurrence amid COVID-19: Robin’s Story
It was the day of the lockdown. My family doctor called. “The colorectal cancer is back in the pelvic sidewall,” she said, “the PET-CT lit up there.” She urged me to get to a hospital right away to get my CEA blood marker taken. When I got there, the clerk refused me, saying “we are closed indefinitely.” But standing behind h...
CONTINUE READING
